Literature DB >> 3908480

Cobalamin malabsorption in three siblings due to an abnormal intrinsic factor that is markedly susceptible to acid and proteolysis.

Y M Yang, R Ducos, A J Rosenberg, P G Catrou, J S Levine, E R Podell, R H Allen.   

Abstract

Three siblings presented in their second year of life with megaloblastic anemia that responded to parenteral cobalamin (Cbl). Schilling tests were less than 1%, correcting to 5 to 15% after addition of hog intrinsic factor (IF). Gastric acid analysis and gastric biopsies were normal by light and electron microscopy. Gastric juice contained less than 3 pmol/ml of Cbl-binding ability due to IF (normal, 10-34 pmol/ml) and less than 2 pmol/ml of IF when measured with a radioimmunoassay (RIA) using normal human IF-[57Co]Cbl and rabbit anti-human IF serum (normal, 17-66 pmol/ml). However, RIA employing rabbit anti-hog IF serum gave values of 4-13 pmol/ml of IF (normal, 11-33 pmol/ml). This material had an apparent molecular weight of 40,000 (normal IF = 70,000). The IF from gastric biopsies appeared normal in terms of Cbl-binding ability, ileal binding, molecular weight, and both RIAs. This IF differed from normal mucosal IF, in that it lost its Cbl-binding ability when incubated at 37 degrees C at acid pH or in the presence of pepsin or trypsin. This loss was retarded when [57Co]Cbl was bound to the IF before these incubations. The stabilizing effects of neutralization and Cbl were also demonstrated in vivo. Schilling tests for the siblings of 0.4, 0.5, and 1.0% increased to 2.7, 5.7, and 4.3% (P less than 0.05), respectively, when the Schilling tests were repeated with the addition of NaHCO3 and cobinamide (which allows Cbl to bind immediately to IF). We conclude that Cbl malabsorption in these children is due to an abnormal IF that is markedly susceptible to acid and proteolytic enzymes which cause a decrease in its molecular weight and Cbl-binding ability and a loss of antigenic determinants that are recognized by the anti-human IF serum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908480      PMCID: PMC424306          DOI: 10.1172/JCI112208

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  Isolation of gastric vitamin B 12 -binding proteins using affinity chromatography. I. Purification and properties of human intrinsic factor.

Authors:  R H Allen; C S Mehlman
Journal:  J Biol Chem       Date:  1973-05-25       Impact factor: 5.157

2.  Congenital pernicious anemia: effects on growth, brain, and absorption of B12.

Authors:  B McNicholl; B Egan
Journal:  Pediatrics       Date:  1968-07       Impact factor: 7.124

3.  Childhood pernicious anemia. Gastrointestinal secretory, histological, and electron microscopic aspects.

Authors:  C B Lillibridge; L L Brandborg; C E Rubin
Journal:  Gastroenterology       Date:  1967-05       Impact factor: 22.682

4.  Juvenile pernicious anemia in sisters.

Authors:  D J Yun; H Lee; G P Chun; K Y Lee
Journal:  Yonsei Med J       Date:  1967       Impact factor: 2.759

Review 5.  Human vitamin B12 transport proteins.

Authors:  R H Allen
Journal:  Prog Hematol       Date:  1975

6.  Juvenile pernicious anaemia.

Authors:  S B Dimson
Journal:  Arch Dis Child       Date:  1966-04       Impact factor: 3.791

7.  Congenital pernicious anemia with coexistent transitory intestinal malabsorption of vitamin B12.

Authors:  B C Lampkin; A M Mauer
Journal:  Blood       Date:  1967-10       Impact factor: 22.113

8.  Characterization of ileal vitamin B12 Binding using homogeneous human and hog intrinsic factors.

Authors:  D C Hooper; D H Alpers; R L Burger; C S Mehlman; R H Allen
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Isolation and characterization of an abnormal human intrinsic factor.

Authors:  M Katz; C S Mehlman; R H Allen
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

10.  RAPID CHARCOAL ASSAY FOR INTRINSIC FACTOR (IF), GASTRIC JUICE UNSATURATED B12 BINDING CAPACITY, ANTIBODY TO IF, AND SERUM UNSATURATED B12 BINDING CAPACITY.

Authors:  K S GOTTLIEBLAU; L R WASSERMAN; V HERBERT
Journal:  Blood       Date:  1965-06       Impact factor: 22.113

View more
  3 in total

1.  Congenital intrinsic factor deficiency in a Spanish patient.

Authors:  A F Remacha; M A Sambeat; M J Barceló; J Mones; J García-Die; E Gimferrer
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

2.  Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis.

Authors:  S K Moestrup; H Birn; P B Fischer; C M Petersen; P J Verroust; R B Sim; E I Christensen; E Nexø
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Hereditary juvenile cobalamin deficiency caused by mutations in the intrinsic factor gene.

Authors:  Stephan M Tanner; Zhongyuan Li; James D Perko; Cihan Oner; Mualla Cetin; Cigdem Altay; Zekiye Yurtsever; Karen L David; Laurence Faivre; Essam A Ismail; Ralph Gräsbeck; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.